Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Exacerbation of Psychosis”

45 trials

Showing 20 of 45 results

Not applicableStudy completedNCT07673718
What this trial is testing

Α-N-acetylgalactosaminidase in Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Elazığ Mental Health and Diseases Hospital 93
Testing effectiveness (Phase 2)Study completedNCT05278156
What this trial is testing

Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Celon Pharma SA 189
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Large-scale testing (Phase 3)Study completedNCT00254202
What this trial is testing

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 593
Testing effectiveness (Phase 2)Study completedNCT01234779
What this trial is testing

RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 301
Testing effectiveness (Phase 2)Study completedNCT00265551
What this trial is testing

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 300
Large-scale testing (Phase 3)Study completedNCT00970281
What this trial is testing

Olanzapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 91
Testing effectiveness (Phase 2)Study completedNCT05227690
What this trial is testing

A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 385
Large-scale testing (Phase 3)Study completedNCT00151424
What this trial is testing

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

Who this might be right for
Schizophrenia
Organon and Co 277
Post-approval studies (Phase 4)Study completedNCT00061802
What this trial is testing

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 225
Testing effectiveness (Phase 2)Study completedNCT04512066
What this trial is testing

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 287
Testing effectiveness (Phase 2)Study completedNCT02477020
What this trial is testing

Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Takeda 164
Not applicableStudy completedNCT02192723
What this trial is testing

Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 550
Large-scale testing (Phase 3)Study completedNCT01098110
What this trial is testing

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

Who this might be right for
Schizophrenia
Organon and Co 532
Testing effectiveness (Phase 2)Study completedNCT00044044
What this trial is testing

A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 356
Large-scale testing (Phase 3)Study completedNCT03345979
What this trial is testing

Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 200
Large-scale testing (Phase 3)Study completedNCT01469039
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 623
Testing effectiveness (Phase 2)WithdrawnNCT00768612
What this trial is testing

Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT01175135
What this trial is testing

An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 259
Testing effectiveness (Phase 2)Study completedNCT00563706
What this trial is testing

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 199
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation